Skip to main content

Table 3 Clinical features of prolactinoma patients with secondary DA resistance between 1981 and 2016

From: Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature 

Characteristic

Value

Gender, male

12

Gender, female

11

Gender, unknown

8

Age (range), years

22–70

Androgen/estrogen replacement therapy

4

Macroadenoma

15

Microadenoma

3

Tumor size not reported

13

Time to secondary resistance (range), years

0.8–15

Malignant prolactinomas

10